上海 [切换城市] 上海招聘上海生物/制药/医疗器械招聘上海生物工程/生物制药招聘

HTS Screener/Operator(职位编号:94473BR)

CNIBR-诺华(中国)生物医学研究有限公司

  • 公司性质:外资(非欧美)
  • 公司行业:制药/生物工程

职位信息

  • 发布日期:2013-07-11
  • 工作地点:上海-浦东新区
  • 招聘人数:1
  • 工作经验:二年以上
  • 学历要求:本科
  • 职位类别:生物工程/生物制药  医药技术研发人员

职位描述

Interested candidte please visit the following URL to apply for the job online (候选人请务必点击以下链接进行在线申请):

https://sjobs.brassring.com/2052/ASP/TG/cim_jobdetail.asp?partnerid=13617&siteid=5271&jobid=1760318&codes=CN14



Job Description:

China Novartis Institutes for Biomedical Research Co. Ltd (CNIBR) is currently seeking to fill a research associate/scientist position in the medium-throughput screening lab. The successful candidate will be part of a multidisciplinary team applying state-of-the-art screening/automation techniques to support our drug discovery and development efforts. The main responsibility for this position is to operate the high throughput robotic systems in support of the compound screening and hit-finding activities. Other responsibilities may include: maintaining and calibrating the offline/online instruments, writing protocols for the liquid handling workstations, and data analysis of the screening dataset. The successful candidate should be highly self-motivated and enjoy working in a highly collaborative environment.


Keywords: CNIBR, NIBR China, NIBR Shanghai, HTS, High-Throughput, High Throughput


Minimum requirements:

Qualified candidate should have a BS or MS degree in the fields of life science or engineering and at least 2-years of working experience in lead-discovery at a pharmaceutical/Biotech Company or an academic screening center. Hands on experiences with the commonly-used HTS equipments (such as plate readers, dispensers, and liquid handlers), and automation are required. Knowledge of the various HTS assay formats is a plus. The candidate is expected to work closely with other project teams, so good communication skill is critical.


公司介绍

诺华(Novartis AG)是全球医药保健行业的领导者。其核心业务涉及专利药,非专利药,眼睛护理,消费者保健和动物保健等领域。诺华公司总部设在瑞士巴塞尔,业务遍及全球140多个国家和地区。

诺华(中国)生物医学研究有限公司是诺华全球研发组织――诺华生物医学研究所(NIBR)的第八个研究基地。我们位于中国上海市张江高科技园区,将成为诺华在亚洲的主要研究中心,以及除在欧美的研究中心外的最主要的研究中心。我们的研究和探索开发活动的重点是发现并开发创新疗法,用于治疗在亚洲远未达到医药需求的疾病。我们与从不同之处在于将专注现代药物的发现和开发方法的研究。最初阶段,研发工作将专注在引起中国地方性癌症的感染原因。我们还将开展临床试验,进行安全性研究,生物标志物和检测分析,表达谱、生物分析以及转化医学的研究。

随着公司业务的迅速扩展,我们热忱欢迎您的加入。同时我们将提供具有竞争力的薪酬福利待遇以及良好的培训发展机会。